(2020) Proactive agenda setting in creation and approval of national action plan for prevention and control of non-communicable diseases in Iran: The use of multiple streams model. Journal of Diabetes and Metabolic Disorders. p. 12.

(2018) Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study. Lancet Gastroenterology & Hepatology. pp. 383-403.

(2018) Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016 A Systematic Analysis for the Global Burden of Disease Study. Jama Oncology. pp. 1553-1568. ISSN 2374-2437

(2018) Scientometric Study on Non-communicable Diseases in Iran: A Review Article. Iranian Journal of Public Health. pp. 936-943. ISSN 2251-6085

(2017) Disability-Adjusted Life-Years (DALYs) for 315 Diseases and Injuries and Healthy Life Expectancy (HALE) in Iran and its Neighboring Countries, 1990-2015: Findings from Global Burden of Disease Study 2015. Archives of Iranian Medicine. pp. 403-418. ISSN 1029-2977

(2017) The Efficacy of 12 Weeks of Sofosbuvir, Daclatasvir, and Ribavirin in Treating Hepatitis C Patients with Cirrhosis, Genotypes 1 and 3. Hepatitis Monthly. p. 4. ISSN 1735-143X

(2017) Estimating the Prevalence of Hepatitis B Virus Infection and Exposure Among General Population in Iran. Hepatitis Monthly. p. 11. ISSN 1735-143X

(2017) Prevalence and Years Lived with Disability of 310 Diseases and Injuries in Iran and its Neighboring Countries, 1990-2015: Findings from Global Burden of Disease Study 2015. Arch Iran Med. pp. 392-402. ISSN 1029-2977

(2017) Trend of Socio-Demographic Index and Mortality Estimates in Iran and its Neighbors, 1990-2015; Findings of the Global Burden of Diseases 2015 Study. Archives of Iranian Medicine. pp. 419-428. ISSN 1029-2977

(2017) Update on the Prevalence of Hepatitis C Virus Infection Among Iranian General Population: A Systematic Review and Meta-Analysis. Hepatitis Monthly. p. 8. ISSN 1735-143X

(2016) Health Research Governance: Introduction of a New Web-based Research Evaluation Model in Iran: One-decade Experience. Iranian Journal of Public Health. pp. 1309-1314. ISSN 2251-6085

(2016) Liver Disease Burden of Hepatitis C Virus Infection in Iran and the Potential Impact of Various Treatment Strategies on the Disease Burden. Hepatitis Monthly. p. 9. ISSN 1735-143X

(2016) Recommendations for the Clinical Management of Hepatitis C in Iran: A Consensus-Based National Guideline. Hepatitis Monthly. p. 14. ISSN 1735-143X

(2015) Historical epidemiology of hepatitis C virus (HCV) in select countries - volume 3. Journal of Viral Hepatitis. pp. 4-20. ISSN 1352-0504

(2015) Is it necessary to screen for celiac disease in adult idiopathic osteoporosis? Gastroenterol Hepatol Bed Bench. pp. 140-5. ISSN 2008-2258 (Print) 2008-2258

(2015) Strategies to manage hepatitis C virus infection disease burden - volume 3. Journal of Viral Hepatitis. pp. 42-65. ISSN 1352-0504

(2015) The present and future disease burden of hepatitis C virus infections with today's treatment paradigm - volume 3. Journal of Viral Hepatitis. pp. 21-41. ISSN 1352-0504

(2014) Surface protein mutations in chronic hepatitis B patients who received hepatitis B vaccine therapy. Iranian Journal of Basic Medical Sciences. pp. 638-645. ISSN 2008-3866

(2012) Identification of Hepatitis B Virus Surface Antigen (HBsAg) Genotypes and Variations in Chronic Carriers from Isfahan Province, Iran. Iranian Journal of Public Health. pp. 104-111. ISSN 2251-6085

(2012) The prevalence of hepatitis B virus surface antigen (HBsAg) variations and correlation with the clinical and serologic pictures in chronic carriers from Khorasan province, North-East of Iran. Acta Med Iran. pp. 265-272. ISSN 00446025 (ISSN)

(2011) Treatment of Chronic Hepatitis C Infection: Update of the Recommendations from Scientific Leader's Meeting-28th July 2011-Tehran, IR Iran. Hepatitis Monthly. pp. 703-713. ISSN 1735-143X

(2010) Hepatitis B Virus Surface Antigen Variants Clustered Within Immune Epitopes in Chronic Hepatitis B Carriers from Hormozgan Province, South of Iran. Iranian Journal of Basic Medical Sciences. pp. 213-224. ISSN 2008-3866

(2010) Seroprevalence and Risk Factors of Hepatitis A Virus Infection in Iran: a Population Based Study. Archives of Iranian Medicine. pp. 99-104. ISSN 1029-2977

(2010) Seroprevalence of hepatitis C virus: the first population-based study from Iran. International Journal of Infectious Diseases. E113-E116. ISSN 1201-9712

(2007) Phylogenetic analysis of HBV based on PreS region in Iranian hepatocellular carcinoma patients. Hepatitis Monthly. pp. 201-205. ISSN 1735-143X

(2006) Combined passive and active immunoprophylaxis for preventing perinatal transmission of the hepatitis B virus in infants born to HBsAg positive mothers in comparison with vaccine alone. Hepatology Research. pp. 265-271. ISSN 1386-6346